Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Levoleucovorin
×
1 year
×
Clear all
Filters
3
NCT06469944
2026-03-16
MK-3475-06C
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
160 enrolled
NCT04949256
2025-12-15
MK-7902-014
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
864 enrolled